Multimodal Imaging in Black and White People with Multiple Sclerosis on Ocrelizumab: A Pilot Study (P3-1.012)
We investigated the differences in the impact of ocrelizumab on AMRIMs between black and white pwMS over a 12-month follow-up period.
Authors
- Zahid Latif (ORCID: https://orcid.org/0000-0001-6735-7555)
- David Clayton (ORCID: https://orcid.org/0000-0002-3850-8200)
- Ibraheem Abioye
- Muhammad Faraz Raghib (ORCID: https://orcid.org/0000-0002-8506-5414)
- Evanthia Bernitsas (ORCID: https://orcid.org/0000-0001-9382-1008)
- Jacob Rube
- Eman Dannawey
- Zaima Liaquat
- Rajiv Gandhi (ORCID: https://orcid.org/0000-0002-2008-2301)
- Fen Bao
- Carla Martinez
- Idan Hannawa
Institutions
- Wayne State University (US)
- Detroit Medical Center (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000211407
- Primary Topic
- Cytokine Signaling Pathways and Interactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00